Etanidazole

Etanidazole
Names
	Preferred IUPAC name N-(2-Hydroxyethyl)-2-(2-nitro-1H-imidazol-1-yl)acetamide
Identifiers
CAS Number	22668-01-5 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL47405 ;
ChemSpider	3161 ;
DrugBank	DB12736;
ECHA InfoCard	100.164.363
PubChem CID	3276;
UNII	30DKA3Q1HL ;
CompTox Dashboard (EPA)	DTXSID8045434 ;
	InChI InChI=1S/C7H10N4O4/c12-4-2-8-6(13)5-10-3-1-9-7(10)11(14)15/h1,3,12H,2,4-5H2,(H,8,13) Key: WCDWBPCFGJXFJZ-UHFFFAOYSA-N ;
	SMILES O=[N ]([O-])c1nccn1CC(=O)NCCO;
Properties
Chemical formula	C7H10N4O4
Molar mass	214.181 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Etanidazole is a nitroimidazole drug that was investigated in clinical trials for its radiosensitizing properties in cancer treatment. Administration of etanidazole results in a decrease of glutathione concentration and inhibits glutathione S-transferase.^[1]^[2] The result is that tissues become more sensitive to the ionizing radiation.^[3]

References

^ Definition of etanidazole, National Cancer Institute Drug Dictionary.
^ DrugBank DB12736 . Accessed 27 April 2021.
^ Inanami, O.; Sugihara, K.; Okui, T.; Hayashi, M.; Tsujitani, M.; Kuwabara, M. (2002). "Hypoxia and etanidazole alter radiation-induced apoptosis in HL60 cells but not in MOLT-4 cells". International Journal of Radiation Biology. 78 (4): 267–274. doi:10.1080/09553000110105695. PMID 12020438. S2CID 37923448.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.